{"protocolSection":{"identificationModule":{"nctId":"NCT04701619","orgStudyIdInfo":{"id":"BMR_2020_31"},"organization":{"fullName":"Fondation Ophtalmologique Adolphe de Rothschild","class":"NETWORK"},"briefTitle":"Immuno-inflammatory Profile and Response to Ischemic Stroke Reperfusion Therapies (IMMUNOSTROKE)","officialTitle":"Immuno-inflammatory Profile and Response to Ischemic Stroke Reperfusion Therapies","acronym":"IMMUNOSTROKE"},"statusModule":{"statusVerifiedDate":"2023-07","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-01-15","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2025-10-15","type":"ESTIMATED"},"completionDateStruct":{"date":"2026-05-15","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-11-25","studyFirstSubmitQcDate":"2021-01-07","studyFirstPostDateStruct":{"date":"2021-01-08","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-11-20","lastUpdatePostDateStruct":{"date":"2023-11-21","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Fondation Ophtalmologique Adolphe de Rothschild","class":"NETWORK"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"IMMUNOSTROKE study aims to describe the immuno-inflammatory and thrombo-inflammatory profiles during the course of AIC management by reperfusion treatment and to monitor changes in these different parameters over time. Post-hoc analyses will make it possible to correlate the immuno-inflammatory and thrombo-inflammatory profiles and their evolution with the clinical outcome in terms of post-AIC functional and cognitive disability."},"conditionsModule":{"conditions":["Stroke","Ischemic Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","interventionModelDescription":"All patients undergoing a reperfusion procedure as part of an ischemia stroke will be able to participate in the study.","primaryPurpose":"OTHER","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":300,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Immuno-inflammatory profile description in patients with ischemic stroke","type":"OTHER","description":"Patients will be evaluated for inflammatory biomarkers at inclusion, at 24-48 hours of reperfusion treatment , at 72 hours, at 7 days or at discharge if before D7, at discharge if after D7, at 3 months and at 1 year.The biomarkers will be measured using ELISA panels for inflammatory biomarkers","interventionNames":["Other: Immuno-inflammatory profile description in patients with ischemic stroke"]}],"interventions":[{"type":"OTHER","name":"Immuno-inflammatory profile description in patients with ischemic stroke","description":"Patients will be evaluated for inflammatory biomarkers at inclusion, at 24-48 hours of reperfusion treatment , at 72 hours, at 7 days or at discharge if before D7, at discharge if after D7, at 3 months and at 1 year.The biomarkers will be measured using ELISA panels for inflammatory biomarkers","armGroupLabels":["Immuno-inflammatory profile description in patients with ischemic stroke"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Immuno-inflammatory profile description in patients with ischemic stroke and eligible for reperfusion treatment","description":"Patients will be evaluated for inflammatory biomarkers at inclusion, at 24-48 hours of reperfusion treatment , at 72 hours, at 7 days or at discharge if before D7, at discharge if after D7, at 3 months and at 1 year.The biomarkers will be measured using ELISA preconfigurated panels for inflammatory biomarkers.","timeFrame":"Up to year"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Presenting an ISCHEMIC STROKE for which reperfusion treatment is indicated according to European and North American recommendations (intraveinous thrombolysis or mechanical thrombectomy or a combination of both)\n\nExclusion Criteria:\n\n* Contraindication to performing a cerebral MRI (claustrophobia, pacemaker or other implantable device contraindicating the performance of MRI)\n* Intracranial haemorrhage associated with AIC on initial imaging\n* Immunosuppressive treatment or corticosteroid therapy on admission of the patient\n* Pre-existing neurological disability limiting the neurological assessment to 3 months (mRS\\>2 on admission)\n* Dementia known and diagnosed pre-existing at ischemic stroke\n* Absolute or relative contraindication to gadolinium injection (history of true allergic reaction or intolerance to gadobutrol, renal failure with creatinine clearance \\<15mL/min, pregnant or breastfeeding woman).","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"90 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Benjamin Maier","role":"CONTACT","phone":"0148036556","email":"nmaier@for.paris"},{"name":"AmÃ©lie Yavchitz","role":"CONTACT","phone":"0148036556","email":"ayavchitz@for.paris"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}